BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.46B
AUM Growth
+$355M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1
+$84.9M
2
+$39.5M
3
+$31.3M
4
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
+$13.4M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$12.5M

Top Sells

1
+$73.8M
2
+$31.3M
3
+$23.9M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
+$10.8M
5
MDVN
MEDIVATION, INC.
MDVN
+$6.92M

Sector Composition

1 Healthcare 83.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$369M 14.99%
3,889,298
-330,000
2
$298M 12.1%
2,795,596
-692,900
3
$258M 10.48%
6,636,526
-70,000
4
$211M 8.58%
4,301,867
+138,077
5
$152M 6.19%
1,354,445
-50,000
6
$141M 5.75%
2,859,412
-140,000
7
$121M 4.9%
727,428
8
$116M 4.72%
1,890,521
+1,384,521
9
$114M 4.63%
476,991
-100,000
10
$85.9M 3.49%
731,542
11
$84M 3.42%
233,000
12
$75.2M 3.06%
1,093,476
+195,000
13
$61M 2.48%
781,288
+160,000
14
$58.5M 2.38%
6,430,532
+583,968
15
$57.6M 2.34%
2,745,040
16
$48.8M 1.99%
3,116,552
+30,000
17
$39.5M 1.61%
+636,773
18
$33.5M 1.36%
3,165,816
19
$31.3M 1.27%
+375,000
20
$31.1M 1.27%
2,320,737
+815,000
21
$25.3M 1.03%
558,188
22
$19M 0.77%
704,582
23
$12.8M 0.52%
1,279,340
-500,000
24
$12.7M 0.52%
743,244
-190,000
25
$4.16M 0.17%
683,522
-1,780,000